HRH2 and schizophrenia: Moreover, in a placebo-controlled, randomized clinical trial, famotidine has been observed to be beneficial to both the positive and negative symptoms in treatment-resistant schizophrenia, implying that H2R antagonism may provide a new alternative for the treatment of schizophrenia.